中危和高危前列腺癌患者的原发分期:多参数MRI与68Ga-PSMA-PET/MRI——单独多参数MRI定量数据或结合临床信息的价值
回顾性纳入49例中高危前列腺癌患者,比较mpMRI与68Ga-PSMA-PET/MRI对包膜外侵犯(≥T3)和区域淋巴结转移(N1)的诊断准确性。≥T3的AUC两组相似(mpMRI 0.72、0.62 vs PET/MRI 0.71、0.72,p>0.38);N1的AUC PET/MRI更高(0.72、0.78 vs mpMRI 0.39、0.55,p<0.01)。2018 Briganti模型预测N1的AUC为0.89,结合临床与mpMRI定量数据可能有助于筛选受益于68Ga-PSMA-PET/MRI分期的患者。
要点
- N1诊断AUC:mpMRI读者0.39、0.55 vs 68Ga-PSMA-PET/MRI读者0.72、0.78(p<0.01),PET/MRI更高。
- ≥T3诊断AUC:mpMRI读者0.72、0.62 vs PET/MRI读者0.71、0.72(p>0.38),两者可比。
- 2018 Briganti模型预测N1的AUC达0.89,结合临床与mpMRI定量数据可辅助筛选PET/MRI分期对象。
核心结论
- ≥T3的读者间一致性mpMRI与68Ga-PSMA-PET/MRI相似,N1的一致性PET/MRI更高;≥T3诊断准确性两者可比,N1诊断准确性PET/MRI和2018 Briganti模型更高;2018 Briganti模型结合临床数据与mpMRI定量数据预测淋巴结转移的AUC最高,可能有助于筛选将从68Ga-PSMA-PET/MRI原发分期中获益的患者。
研究设计与样本
- 回顾性研究,纳入2016年1月至2019年2月期间接受68Ga-PSMA-PET/MRI和mpMRI的前列腺癌患者49例(中位年龄66岁,IQR 61-72岁),以根治性前列腺切除术(n=35/49)为参考标准。
诊断标准与关键数值
- 两名读者分别在68Ga-PSMA-PET/MRI或mpMRI上以Likert量表评估包膜外侵犯(≥T3)和区域淋巴结转移(N1)。
- 第五名读者在mpMRI上测量肿瘤体积、最大直径和包膜接触长度;另用2018 Briganti模型计算淋巴结转移概率。
- ≥T3诊断AUC:mpMRI读者0.72、0.62 vs 68Ga-PSMA-PET/MRI读者0.71、0.72(p>0.38)。
- N1诊断AUC:mpMRI读者0.39、0.55 vs 68Ga-PSMA-PET/MRI读者0.72、0.78(p<0.01)。
- mpMRI定量参数对≥T3的诊断AUC为0.70-0.72;2018 Briganti模型对N1的AUC为0.89。
临床应用与阅片要点
- 读者间一致性(平方Cohen kappa):≥T3为mpMRI 0.58 vs 68Ga-PSMA-PET/MRI 0.47;N1为mpMRI 0.55 vs 68Ga-PSMA-PET/MRI 0.92。
- 作者认为,在2018 Briganti模型中结合临床数据与mpMRI定量数据预测淋巴结转移的AUC最高,可能有助于筛选将从68Ga-PSMA-PET/MRI原发分期中获益的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Comparing mpMRI and 68Ga-PSMA-PET/MRI in primary staging of PCa and investigating the value of quantitative mpMRI-measurements for prediction of extracapsular extension and N-metastases.
METHODS: Patients with PCa undergoing 68Ga-PSMA-PET/MRI and mpMRI during January 2016 to February 2019 were retrospectively included. Two readers each on 68Ga-PSMA-PET/MRI or mpMRI rated extraprostatic extension (≥T3) and regional lymph-node-metastasis (N1) on a Likert-scale. A fifth reader measured tumor volume, maximum diameter, and capsular contact length on mpMRI. Probability of lymph-node-metastasis was additionally calculated using the 2018 Briganti model. Interobserver-agreement was assessed by squared Cohen's kappa, and diagnostic accuracy was determined using radical prostatectomy (n = 35/49) as reference standard.
RESULTS: 49 patients (median age 66 years [IQR: 61-72 years]) were evaluated. Interobserver-agreement for mpMRI and 68Ga-PSMA-PET/MRI was: ≥T3: κ = 0.58/0.47; N1: κ = 0.55/0.92. Diagnostic accuracy for mpMRI vs 68Ga-PSMA-PET/MRI readers for ≥ T3 was AUC: 0.72, 0.62 vs 0.71, 0.72 (p > 0.38) and for N1 was AUC: 0.39, 0.55 vs 0.72, 0.78 (p < 0.01). Quantitative parameters delivered diagnostic accuracies of: AUC: 0.70-0.72 for ≥ T3. The 2018 Briganti model achieved an AUC of 0.89 for N1.
CONCLUSIONS: Interreader-agreement regarding ≥ T3 was similar for mpMRI and 68Ga-PSMA-PET/MRI while for N1 it was higher for 68Ga-PSMA-PET/MRI. Diagnostic accuracy was comparable for ≥ T3 while for N1 it was higher in 68Ga-PSMA-PET/MRI and the 2018 Briganti model. Combining clinical data and quantitative data from mpMRI in the 2018 Briganti model yielded the highest AUC for prediction of lymph node metastasis and may aid in selecting patients who will benefit from 68Ga-PSMA-PET/MRI for primary staging.
引用
- Skawran, Sanchez, Ghafoor, et al. Primary staging in patients with intermediate- and high-risk prostate cancer: Multiparametric MRI and 68Ga-PSMA-PET/MRI - What is the value of quantitative data from multiparametric MRI alone or in conjunction with clinical information? Eur J Radiol. 2021. PMID: 34844173. doi:10.1016/j.ejrad.2021.110044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。